These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 17473280)
21. Is bypass surgery better than stenting? Excellent long-term outcomes may make surgery a wiser choice for some patients. Duke Med Health News; 2007 May; 13(5):3. PubMed ID: 17580405 [No Abstract] [Full Text] [Related]
22. Impact of the Food and Drug Administration's Public Health Notification on the adoption of drug-eluting stents. Curtis JP; Cohen DJ; Jones PG; Bach RG; Spertus JA; Krumholz HM Am J Cardiol; 2007 May; 99(9):1227-9. PubMed ID: 17478147 [TBL] [Abstract][Full Text] [Related]
23. The off- versus on-label use of medical devices in interventional cardiovascular medicine: clarifying the ambiguity between regulatory labeling and clinical decision-making, Part 1: PCI. Price MJ; Teirstein PS Catheter Cardiovasc Interv; 2008 Oct; 72(4):500-4. PubMed ID: 18814224 [TBL] [Abstract][Full Text] [Related]
24. Report from the meeting of the Circulatory System Devices Panel of the Food and Drug Administration Center for Devices and Radiologic Health: September 21, 2004. Maisel WH; Circulation; 2005 Apr; 111(16):2143-5. PubMed ID: 15851621 [No Abstract] [Full Text] [Related]
25. Revised draft guidance document for breast implants. FDA Consum; 2004; 38(2):4. PubMed ID: 15101353 [No Abstract] [Full Text] [Related]
26. Technologies that deliver. Basu P Nat Med; 2003 Sep; 9(9):1100-1. PubMed ID: 12949511 [No Abstract] [Full Text] [Related]
27. Update on drug-eluting stents. Sims JM Dimens Crit Care Nurs; 2007; 26(6):237-40. PubMed ID: 18090139 [TBL] [Abstract][Full Text] [Related]
28. Cardiac relief. Stent prices could drop with FDA approvals ahead. Hensley S Mod Healthc; 1997 Jul; 27(28):86. PubMed ID: 10168525 [No Abstract] [Full Text] [Related]
29. President's page: Fellow physicians: read, respond, repeat: thoughts on our obligations relative to the media. Pepine CJ J Am Coll Cardiol; 2004 Mar; 43(5):891-2. PubMed ID: 14998633 [No Abstract] [Full Text] [Related]
30. Clinical use of sirolimus-eluting stents. Kirtane AJ; Leon MB Cardiovasc Drug Rev; 2007; 25(4):316-32. PubMed ID: 18078432 [TBL] [Abstract][Full Text] [Related]
31. Exploring emerging nanobiotechnology drugs and medical devices. Paradise J; Diliberto GM; Tisdale AW; Kokkoli E Food Drug Law J; 2008; 63(2):407-20. PubMed ID: 18561467 [No Abstract] [Full Text] [Related]
32. Medical devices: problems on the rise. Consum Rep; 2007 Dec; 72(12):53. PubMed ID: 18038480 [No Abstract] [Full Text] [Related]
33. Missing evidence. Hayes WS MLO Med Lab Obs; 2008 Oct; 40(10):68. PubMed ID: 18988559 [No Abstract] [Full Text] [Related]
34. Allergic reactions following implantation of drug-eluting stents: a manifestation of Kounis syndrome? Kounis NG; Kounis GN; Kouni SN; Soufras GD; Niarchos C; Mazarakis A J Am Coll Cardiol; 2006 Aug; 48(3):592-3; author reply 593-4. PubMed ID: 16875994 [No Abstract] [Full Text] [Related]
35. Assessing the impact of drug-eluting stents. Hospitals must be prepared to absorb a potentially negative financial impact. Pfeiffer H Healthc Exec; 2003; 18(4):60-1. PubMed ID: 12841062 [No Abstract] [Full Text] [Related]
36. Drug delivery: the strategic advantage of design controls. Donawa ME Med Device Technol; 1999 May; 10(4):12-4. PubMed ID: 10539104 [TBL] [Abstract][Full Text] [Related]
37. The drug-eluting stent information gap. Yock CA; Yock PG Am Heart Hosp J; 2004; 2(1):21-5. PubMed ID: 15604835 [TBL] [Abstract][Full Text] [Related]